Who funds Alzheimer's disease drug development?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Who funds Alzheimer's disease drug development?

Published:2021-01 Issue:1 Volume:7 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Cummings Jeffrey¹,Bauzon Justin²,Lee Garam³

Affiliation:

1. Chambers‐Grundy Center for Transformative Neuroscience Department of Brain Health School of Integrated Health Sciences University of Nevada Las Vegas (UNLV) Las Vegas Nevada USA

2. University of Nevada Las Vegas (UNLV) School of Medicine Las Vegas Nevada USA

3. Biogen, Medical Affairs Weston Massachusetts USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12185

Reference36 articles.

1. 2019 Alzheimer's disease facts and figures

2. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

3. Alzheimer's disease drug development pipeline: 2020

4. Economic analysis of opportunities to accelerate Alzheimer's disease research and development

5. The price of progress: Funding and financing Alzheimer's disease drug development

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate;Molecular Neurodegeneration;2023-06-06

2. Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022;Neurology and Therapy;2023-04-05

3. Epilepsy and Alzheimer’s Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies;Current Neuropharmacology;2022-11

4. Domino-like Effect of C112R Mutation on ApoE4 Aggregation and Its Reduction by Alzheimer’s Disease Drug Candidate;2022-10-09

5. Alzheimer's disease drug development pipeline: 2022;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3